Elevance Health ( (ELV) ) has provided an announcement.
Elevance Health, Inc. announced its expectations for the first quarter of 2025, projecting a GAAP net income of $9.61 per diluted share, with adjusted net income at $11.97 per diluted share after accounting for net unfavorable items. The company noted that medical cost trends, particularly in its Medicare Advantage business, aligned with their expectations, and they anticipate maintaining their full-year guidance for Medicare Advantage membership and adjusted net income.
Spark’s Take on ELV Stock
According to Spark, TipRanks’ AI Analyst, ELV is a Outperform.
Elevance Health shows strong financial performance with consistent revenue growth and stable profitability. The technical analysis indicates a positive trend with caution due to potential resistance. Valuation metrics suggest the stock is fairly priced. The recent earnings call highlighted strong growth in key segments but also noted challenges with Medicaid cost trends. Overall, Elevance Health is well-positioned but must manage cash flow and Medicaid challenges effectively.
To see Spark’s full report on ELV stock, click here.
More about Elevance Health
Elevance Health, Inc. operates in the healthcare industry, focusing on providing health insurance services, including Medicare Advantage plans.
YTD Price Performance: 18.42%
Average Trading Volume: 1,691,452
Technical Sentiment Signal: Sell
Current Market Cap: $99.11B
Learn more about ELV stock on TipRanks’ Stock Analysis page.